Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
ESMO Open|August 5, 2025
Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trialD Melisi, T Macarulla, C De La Fouchardière, et al.
ESMO Open|June 5, 2024
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202A Vogel, V Sahai, A Hollebecque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2019
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparibP Hammel, H L Kindler, M Reni, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)E Van Cutsem, D Cunningham, W W Ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR GroupT André, D Vernerey, S A Im, et al.
Acta Gastro-Enterologica Belgica|December 15, 2020
Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi methodP-J Cuyle, K Geboes, S Carton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2018
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300Y-J Bang, E Yañez Ruiz, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2013
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)R A Popescu, R Schäfer, R Califano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2016
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized studyS Faivre, P Niccoli, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2018
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III studyT Yoshino, D C Portnoy, R Obermannová, et al.
Pageof 23